Carminomycin (NSC-180024): a phase I study.
D000328:Adult; D000368:Aged; D002360:Carubicin / Q000627:therapeutic use / Q000633:toxicity*; D003630:Daunorubicin / Q000031:analogs & derivatives*; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*; D013921:Thrombocytopenia / Q000139:chemically induced
D002360:Carubicin; D003630:Daunorubicin